Skip to main content
Advertisement
Advertisement

RCEL

RCEL logo

Avita Medical, Inc. Common Stock

10.95
USD
Sponsored
-0.54
-4.70%
Sep 23, 16:00 UTC -4
Closed
exchange

After-Market

10.93

-0.02
-0.23%

RCEL Earnings Reports

Positive Surprise Ratio

RCEL beat 8 of 18 last estimates.

44%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.64M
/
-$0.22
Implied change from Q2 26 (Revenue/ EPS)
+4.34%
/
-12.00%
Implied change from Q3 25 (Revenue/ EPS)
+32.72%
/
-52.17%

Avita Medical, Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, RCEL reported earnings of -0.25 USD per share (EPS) for Q2 26, beating the estimate of -0.29 USD, resulting in a 14.50% surprise. Revenue reached 21.70 million, compared to an expected 20.57 million, with a 5.50% difference. The market reacted with a +63.58% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 22.64 million USD, implying an decrease of -12.00% EPS, and increase of 4.34% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Avita Medical, Inc. Common Stock reported EPS of -$0.25, beating estimates by 14.5%, and revenue of $21.70M, 5.5% above expectations.
The stock price moved up 63.58%, changed from $4.75 before the earnings release to $7.77 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on 5 analysts, Avita Medical, Inc. Common Stock is expected to report EPS of -$0.22 and revenue of $22.64M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement